The opioid crisis most likely is the most profound public health crisis our nation has faced. In 2015 alone, 52,000 people died of drug overdoses, with over 30,000 of those people dying from opioid drugs. Recent Findings show that the majority of opioid abusers begin their addiction with prescription medications, primarily for chronic pain. Chronic postoperative pain, which occurs in 10–50 percent of surgical patients, is a major concern in many types of surgery.
The effects of the opioid epidemic are felt in all areas of the United States, especially in the health care industry. Emergency department visits are mounting, billions of dollars are spent annually on medical care and treatments for addictions, and socioeconomic effects of this crisis contribute to increasing depression, anxiety, missed days of work or school, unemployment, drop-out rates, and loss of productivity among those addicted to opioids.
Providers face an imperative to mediate patient pain following a complicated medical procedure. This is not only the humane thing to do, but is also essential for making sure the patient walks away from the care encounter satisfied. Reconciling the opioid epidemic, pain management, and patient satisfaction becomes even more complicated for providers treating patients with chronic pain.
11 percent of adults experience chronic pain, which can quickly become quality of life issue. Pain impacts the patient experience throughout their daily routines, and may limit participation in work, school, or social activities.
Nationwide, the medical community has made it a priority to ensure that postsurgical analgesia is sufficient to control pain without increasing non-medically appropriate opioid use. Numerous factors, including the inappropriate prescription of opioids, lack of understanding of the potential adverse effects of long-term therapy, opioid misuse, abuse, and dependence, have contributed to the current crisis.
Part of the opioid crisis can be attributed to the poor management with which oncologists, primary care physicians,
dentists, surgeons, and emergency room physician’s direct opioid therapy in regards to continuing prescriptions in opioid dependent patients, and starting opioid therapy in patients who are opioid-naïve.
Despite the acute analgesic efficacy in taking opioids, numerous harmful effects have been associated with its administration. Opioid-associated adverse events have significantly impacted health care costs.
Analysis of 320,000 surgeries found that 12.2 percemt of patients with opioid-related adverse drug events had prolonged hospital stays (7.6 vs. 4.2 days) and greater costs ($22,000 vs. $17,000) relative to patients without opioid-related adverse drug events. Patients with reported opioid-related adverse drug events have been reported to have a 36% increased risk 30- day readmission, 55 percent prolonged hospitalization, increased risk of inpatient mortality by 3.4-fold, and 47 percent increased cost of care compared to patients who did not report opioid-related adverse drug events.
Patients on opioid therapy that is continued for 90 days or more are more likely to stay on chronic opioid therapy for years.
Improve Patient Experiences
Significantly improve patient experiences through real-time point of care data, providing more relevant information to patients on their opioid usage and how to manage it.
Warning Sign Identification
Identify and understand the warning signs that lead to problematic usage and addiction and earlier identification of adverse drug events.
Connect Patients with Support
Ability to immediately connect patients with supports they need as soon as they need them. Better program management and support with practitioner-engaged real-time adherence and dosage monitoring.
Real-time monitoring and interventions will reduce readmissions and optimize costs for at risk patient populations.
Lower Addiction Rates
Reduced addiction opportunities and rates through better direct patient support, real-time monitoring, and early intervention before drug dependencies evolve.
We can decrease rates of serious adverse drug events, lowering 30-day admissions and prolonged hospitalization, and reducing inpatient mortality rates.
System Cost Savings
significant direct and supplementary cost savings from lower readmission rates and proactive, preventative care.